Dr. Reddy's Laboratories - Jobs & Pipeline | Formulate

Dr. Reddy's Laboratories

GA - NorcrossPharmaceutical1 H-1B visas (FY2023)

Website LinkedIn Careers Page

Focus: Dr. Reddy's Laboratories is a pharmaceutical manufacturer headquartered in Norcross, GA, specializing in small molecules and custom pharma services across oncology, neurology, cardiovascular, infectious disease, and respiratory segments.

Neurology Oncology Cardiovascular Infectious Diseases

Profile data last refreshed 5h ago · AI intelligence enriched 3w ago

Open Jobs

0

About Dr. Reddy's Laboratories

AI assessmentNot Hiring

No open roles listed right now. Follow Dr. Reddy's Laboratories to get notified when they start hiring — the background below is worth knowing for when they do.

Generated by Claude from Dr. Reddy's Laboratories's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

2 in 5yr

LO MINASTRIN FE

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Multiple myeloma (proteasome inhibition)

$14M Part D

Peak14.9yr

Help build intelligence for Dr. Reddy's Laboratories

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effe

N/A

Levofloxacin 500

Chronic Prostatitis

N/A

Clinical Trials (1)

NCT02711943Non Interventional Study of Levofloxacin in Chronic Prostatitis

N/A

Levofloxacin

N/A

Clinical Trials (1)

NCT02712502Levofloxacin in Bacterial Rhinosinussitis

N/A

Fulvestrant

Breast Neoplasm Female

N/A

Clinical Trials (1)

NCT05140655Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

N/A

NISELAT

Knee Osteoarthritis

N/A

Clinical Trials (1)

NCT02865161Amtolmetin Gaucil in Knee Osteoarthritis

N/A

Fluoxetine Hydrochloride

Phase 1

Clinical Trials (1)

NCT01166087Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition

Phase 1

Olanzapine

Phase 1

Clinical Trials (1)

NCT01503398Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

Phase 1

Ondansetron Hydrochloride

Phase 1

Clinical Trials (1)

NCT01511705Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition

Phase 1

Donepezil

Phase 1

Clinical Trials (1)

NCT01923259Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition

Phase 1

Desloratadine

Phase 1

Clinical Trials (1)

NCT01314352Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Phase 1

Ha44

Phase 1

Clinical Trials (1)

NCT01518699Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers

Phase 1

Divalproex Sodium

Phase 1

Clinical Trials (1)

NCT01581788Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions

Phase 1

Amlodipine Besylate / Benazepril Hydrochloride

Phase 1

Clinical Trials (1)

NCT01155895Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

Phase 1

Doxorubicin Hydrochloride Liposome Injection

Ovarian Epithelial Cancer Recurrent

Phase 1

Clinical Trials (1)

NCT02260544Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Phase 1

Omeprazole

Phase 1

Clinical Trials (1)

NCT01170169Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions

Phase 1

Rivastigmine

Phase 1

Clinical Trials (1)

NCT01146067Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Phase 1

Simvastatin

Phase 1

Clinical Trials (1)

NCT01167894Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition

Phase 1

Nizatidine

Phase 1

Clinical Trials (1)

NCT01161927Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions

Phase 1

Desloratadine

Phase 1

Clinical Trials (1)

NCT01506050Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition

Phase 1

DFD-29

Pharmacokinetics

Phase 1

Sertraline

Phase 1

Clinical Trials (1)

NCT01267383Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions

Phase 1

Lamotrigine

Phase 1

Clinical Trials (1)

NCT01888731Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition

Phase 1

Fexofenadine

Phase 1

Clinical Trials (1)

NCT01066767Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions

Phase 1

Donepezil

Phase 1

Clinical Trials (1)

NCT01923558Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

Phase 1

AVT32-DRL_PB

Phase 1

Clinical Trials (1)

NCT07475572Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Phase 1

Omeprazole

Phase 1

Clinical Trials (1)

NCT01045642Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions

Phase 1

Zonisamide

Phase 1

Clinical Trials (1)

NCT01161966Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase 1

Carvedilol

Phase 1

Clinical Trials (1)

NCT01064154Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions

Phase 1

Sirolimus

Phase 1

Clinical Trials (1)

NCT02296749Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition

Phase 1

Isotretinoin

Phase 1

Clinical Trials (1)

NCT01888341Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition

Phase 1

Ramipril

Phase 1

Clinical Trials (1)

NCT01164774Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

Phase 1

Divalproex Sodium

Phase 1

Clinical Trials (1)

NCT01055938Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions

Phase 1

DFN-15 Dose 1

Phase 1

Clinical Trials (1)

NCT03051685Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults

Phase 1

Levetiracetam

Phase 1

Clinical Trials (1)

NCT01132352Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Phase 1

Reminyl

Phase 1

Clinical Trials (1)

NCT01372280Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

Phase 1

Fluconazole

Phase 1

Clinical Trials (1)

NCT01511770Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions

Phase 1

DRL_PG

Pharmacokinetics

Phase 1

Clinical Trials (1)

NCT02205320A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

Phase 1

Lamotrigine

Phase 1

Clinical Trials (1)

NCT01513720Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition

Phase 1

Trandolapril

Phase 1

Clinical Trials (1)

NCT01164787Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions

Phase 1

Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT06193187A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Phase 1

Ramipril

Phase 1

Clinical Trials (1)

NCT01164761Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

Phase 1

Sertraline

Phase 1

Clinical Trials (1)

NCT01267396Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions

Phase 1

Reminyl

Phase 1

Clinical Trials (1)

NCT01372306Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Phase 1

Ibuprofen + Pseudoephedrine Hydrochloride

Phase 1

Clinical Trials (1)

NCT01131780Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions

Phase 1

Divalproex Sodium

Phase 1

Clinical Trials (1)

NCT01056627Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition

Phase 1

Desloratadine

Phase 1

Clinical Trials (1)

NCT01506037Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition

Phase 1

Ibuprofen

Phase 1

Clinical Trials (1)

NCT01149954Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed Conditions

Phase 1

Clopidogrel

Phase 1

Clinical Trials (1)

NCT01621763Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

Phase 1

Metoprolol Succinate

Phase 1

Clinical Trials (1)

NCT01673997Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions

Phase 1

Fexofenadine

Phase 1

Clinical Trials (1)

NCT01066754Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Phase 1